Marker Therapeutics, Inc.Marker Therapeutics, Inc.Marker Therapeutics, Inc.

Marker Therapeutics, Inc.

No trades
See on Supercharts

Price target

10.330.000.00%
The 3 analysts offering 1 year price forecasts for MRKR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to MRKR in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MRKR EPS for the last quarter is −0.22 USD despite the estimation of −0.22 USD. In the next quarter EPS is expected to reach −0.24 USD. Track more of Marker Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Marker Therapeutics, Inc. revenue is expected to reach ‪815.43 K‬ USD. Check out Marker Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, MRKR price target is 10.33 USD with a max estimate of 19.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Marker Therapeutics, Inc. stock price chart and keep track of the current situation with MRKR news and stock market news.